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ARTICLE
Macrophage-derived netrin-1 promotes abdominal
aortic aneurysm formation by activating MMP3 in
vascular smooth muscle cells
Tarik Hadi1, Ludovic Boytard1, Michele Silvestro 1, Dornazsadat Alebrahim1, Samson Jacob2, Jordyn Feinstein1,
Krista Barone1, Wes Spiro3, Susan Hutchison3, Russell Simon1, Debra Rateri4, Florence Pinet 5, David Fenyo2,
Mark Adelman1, Kathryn J. Moore 3, Holger K. Eltzschig6, Alan Daugherty4 & Bhama Ramkhelawon1,7
Abdominal aortic aneurysms (AAA) are characterized by extensive extracellular matrix
(ECM) fragmentation and inflammation. However, the mechanisms by which these events
are coupled thereby fueling focal vascular damage are undefined. Here we report through
single-cell RNA-sequencing of diseased aorta that the neuronal guidance cue netrin-1 can act
at the interface of macrophage-driven injury and ECM degradation. Netrin-1 expression peaks
in human and murine aneurysmal macrophages. Targeted deletion of netrin-1 in macrophages
protects mice from developing AAA. Through its receptor neogenin-1, netrin-1 induces a
robust intracellular calcium flux necessary for the transcriptional regulation and persistent
catalytic activation of matrix metalloproteinase-3 (MMP3) by vascular smooth muscle cells.
Deficiency in MMP3 reduces ECM damage and the susceptibility of mice to develop AAA.
Here, we establish netrin-1 as a major signal that mediates the dynamic crosstalk between
inflammation and chronic erosion of the ECM in AAA.
DOI: 10.1038/s41467-018-07495-1 OPEN
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Medicine, New York University School of Medicine, New York, NY 10016, USA. 4Department of Physiology and Saha Cardiovascular Research Center,
University of Kentucky, Lexington, KY 40506, USA. 5 University of Lille, Inserm U1167, Institut Pasteur de Lille, 59019 Lille, France. 6Department of
Anesthesiology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA. 7Department of Cell Biology,
New York University Medical Center, New York, NY 10016, USA. These authors contributed equally: Tarik Hadi, Ludovic Boytard. Correspondence and
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Abdominal aortic aneurysms (AAA) are distinguished bythe progressive structural impairment of the abdominalaorta due to extensive vascular injury that manifests as
focal arterial enlargement1. Because AAA is generally asympto-
matic2, it is likely that reported prevalence of up to 8% in elderly
men and ~13,000 annual mortality attributed to AAA rupture
are underestimated3. To prevent life-threatening rupture of the
weakened vessels, surgical intervention is still the mainstay
treatment of this complex multifactorial disease4. There is cur-
rently an unmet need to ameliorate surgical approaches or to
develop therapies that delay surgery in order to improve clinical
management of individuals with AAA.
Cumulative efforts to understand the mechanisms that contribute
to the local trauma associated with AAA have consistently high-
lighted the activation of the immune response in the pathological
vascular wall5–7. Recently, microarray-based gene expression studies
have illuminated an overrepresentation of pathways involved in
inflammatory responses8–10, establishing further evidence that AAA
is an immunologic disease with dominant roles described for acti-
vated monocytes/macrophages subsets6. The mechanisms by which
monocyte-derived macrophages are channeled to the AAA location
have been well defined and multiple players including C–X–C motif
receptor 4 (CXCR4)11, chemoattractant protein-1 receptor (CCR2)12
and its ligand chemokine (C–C motif) ligand 2 (CCL2)13 have been
shown to play pivotal roles in directing these steps. The coordinated
action of CCL2 and interleukin-6 (IL-6)14 also nurtured the supply
of monocyte-derived macrophages to the vascular wall in apolipo-
protein E deficient mice (ApoE−/−) exposed to continuous infusion
of angiotensin II (Ang II), a prototypical AAA model15. However,
why and how monocyte/macrophage accrual in the arterial wall
impacts the focal distribution of AAA and the specific role of these
cells in AAA is still unclear.
In healthy aorta characterized by a paucity of active inflam-
matory cell invasion, the consolidated ECM plays an instrumental
role to limit aortic dysfunction16. ECM provides physical scaffold
for cells constituent of the aorta and it is therefore constantly
remodeled to maintain the integrity of the vascular framework16.
In AAA, the chronic catabolic activity of ECM-degrading
enzymes matrix metalloproteinases (MMP) has consistently
been demonstrated to lethally compromise vessel remodeling and
precipitate to aortic rupture17,18. The presence of macrophages is
often associated with MMP activity in AAA suggesting a rela-
tionship between macrophages and ECM metabolism. However,
the mechanisms that regulate such interactions remained unclear
so far. In the quest to identify signals that mediate this crosstalk,
we hypothesized that cues displaying immunoregulatory func-
tions could intercept in this process.
Work from our group has identified netrin-1, a neuronal
guidance cue with unique laminin-like structure, as a key che-
morepulsive protein that directs leukocyte migration19–21. Here,
we directly address the role of netrin-1 in bridging macrophage-
dependent inflammation and sustained ECM damage in AAA.
Using single-cell RNA-sequencing (RNA-seq) of AAA, we iden-
tify that pools of activated macrophages express netrin-1. The
deficiency of netrin-1 in hematopoietic lineage and in macro-
phages protects mice from developing AAA compared to wild
type (WT) littermates. Netrin-1 modulates calcium mobilization
in neighboring vascular smooth muscle cells (VSMCs) via its
receptor, neogenin-1. Activation of neogenin-1 by netrin-1 is
required for the nuclear translocation of the transcription factor
nuclear factor of activated T-cells, cytoplasmic 3 (NFATc3) to
potentiate the catalytic activity of matrix metalloproteinase-3
(MMP3). The deletion of MMP3 protects mice from developing
AAA. Our data suggest that locally activated macrophages leave a
netrin-1 imprint in AAA, thereby fueling MMP3 activation by
VSMCs and fostering focal degradation of the ECM that man-
ifests in AAA.
Results
Netrin-1 is predominant in murine and human AAA. Trans-
mural inflammation is detrimental to ECM integrity in AAA.
Important roles of netrin-1 in orchestrating inflammation have
been established20,22–24. In the quest to identify signals that can
coordinate focal vascular injury and sustained inflammation in
AAA, we hypothesized that netrin-1 could play a role in this
context. We first characterized the level of netrin-1 in diseased
sections of the aorta in an established murine AAA modeled
through the infusion of Ang II in ApoE−/− mice15. Quantitative
RT-PCR revealed that netrin-1 mRNA (Ntn1) expression was
significantly increased in AAA aortas compared to healthy tissues
exposed to PBS. A similar expression pattern of inflammatory
markers adhesion G-protein-coupled receptor E1 (Adgre1),
interleukin 6 (Il6) and the C-C motif chemokine 2 (Ccl2) was
observed in the aortas, consistent with previous reports25
(Fig. 1a). Western blot analysis confirmed a marked increase in
the expression of netrin-1 within the AAA loci compared to
healthy aortas (Fig. 1b). This coincided with immunofluorescence
staining of aortic sections that revealed a pronounced pattern for
netrin-1 in cellular and acellular structures, both in murine tissues
(Fig. 1c) as well as in human sections (Fig. 1d). Collectively, these
results suggested that the accumulation of netrin-1 may play a
causative role in AAA.
Netrin-1 deficiency in hematopoietic lineage prevents AAA. To
gain insight into the role of netrin-1 in the development of AAA,
we investigated the impact of the lack of netrin-1 in AAA. To
circumvent the embryonic lethality of netrin-1 deficiency,
we used a fetal liver transplant strategy where lethally irradiated
recipient ApoE−/− mice were reconstituted with either
Ntn1−/−ApoE−/− or Ntn1+/+ApoE−/− day-14 embryonic cells.
We therefore generated Ntn1−/−ApoE−/− (Ntn1−/−→ApoE−/−)
or Ntn1+/+ApoE−/− (WT→ApoE−/−) spontaneously hypercho-
lesterolemic chimera mice that we challenged to Ang II or PBS for
28 days after transplantation recovery. While Ang II infusion
increased the blood pressure from day 0 to day 28, no different
pro-hypertensive effects were observed between chimeric
Ntn1−/−→ApoE−/− and WT→ApoE−/− animals (Fig. 2a).
Interestingly, although ~70% of the WT→ApoE−/− animals
developed AAA, only ~25% of Ntn1−/−→ApoE−/− mice showed
features of the disease (Fig. 2b). Analysis of the detailed severity of
AAA classified by stages, as previously described26, showed that
Ntn1−/−→ApoE−/− chimeras were protected from developing
complex manifestations of AAA typified by prominent aortic
bulging and transmural thrombus in the supra-renal regions
(Fig. 2c, d). To closely profile the hemodynamic features and non-
invasively monitor the progression of aortic enlargement, we
performed color Doppler ultrasound imaging weekly. Consistent
with the incidence of AAA, turbulent flow patterns illustrated by
dual-color blood flow profiles and aliasing effects were captured
longitudinally in WT→ApoE−/− mice in contrast to the laminar
flows acquired in the supra-renal region of Ntn1−/−→ApoE−/−
mice treated Ang II (Fig. 2e). These prototypical features manifest
in the human pathology and were recapitulated in our present
chimeric murine models. Notably, vessel dilatation was markedly
increased in WT→ApoE−/− mice exposed to Ang II compared to
PBS treated mice, however, the aortic diameter was reduced in
Ntn1−/−→ApoE−/−mice treated with Ang II (Fig. 2f). These data
suggested that the absence of netrin-1 in the hematopoietic
compartment could protect against the development of AAA.
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Fig. 1 Netrin-1 is highly expressed in human and murine AAA. a Quantitative PCR analysis of Ntn1, Adgre1, Ccl2, and Il6 mRNA levels isolated from aortas of
ApoE−/− mice exposed to PBS or Ang II for 28 days (n= 8/9 mice per group). *P < 0.05, ***P < 0.001. bWestern blot analysis of netrin-1 in aorta extracts
normalized to loading control, GAPDH (n= 3 mice per group). AU arbitrary units. ** P < 0.01. Representative microscopy staining of netrin-1 and cell nuclei
(DAPI, blue) in magnified aortic sections (dashed box) from PBS and Ang II infused ApoE−/− mice (c) (whole aortic section is shown in left top and
bottom, scale bar 200 µm, magnified areas on the right, scale bar 20 µm) and human specimens (d); Hematoxylin and eosin (H&E; scale bar 500 µm)
staining showing magnified sections (1, 2; scale bar 20 µm); arrows indicate acellular localization of netrin-1; L lumen, A adventitia. Unpaired, two-tailed t-
test was used for statistical analysis. Error bars represent s.e.m
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Since inflammation and ECM degradation are key hallmarks of
AAA, we therefore assessed macrophage infiltration and
elastin damage. The accrual of macrophages characterized by
mRNA abundance of Adgre1 (Fig. 2g) and immunostaining
directed against CD68 (Fig. 2h) was significantly reduced in
Ntn1−/−→ApoE−/− as opposed to WT→ApoE−/− aortas that
were prone to AAA. Extensive elastin damage depicted by focal
breaks and fiber thinning was consistently observed across the
circumference of the aortic sections of the WT→ApoE−/− mice
whereas those examined from Ntn1−/−→ApoE−/− sections
were in opposite mirror to the latter findings (Fig. 2i). These
exciting key observations predicted that the expression of netrin-1
could contribute to elastin damage and precipitate to vessel
rupture. To test this hypothesis, we subjected a subgroup of older
mice (~11 months) to high dose of Ang II as previously descri-
bed14. While mortality peaked to 80% in the WT→ApoE−/−
group, 80% of the Ntn1−/−→ApoE−/− mice survived after
28 days of treatment (Fig. 2j). Altogether, these findings clearly
indicated a seminal role for hematopoietic-derived netrin-1 in
steering the destruction of the aortic wall in AAA.
Unique signature of netrin-1 in aortic macrophage subset. In
the aim to define which cellular entity among the hematopoietic
lineage was responsible for the expression of netrin-1, we profiled
the transcriptome landscape of murine AAA through single-cell
RNA-seq. Using t-distributed stochastic neighbor embedding (t-
SNE) nonlinear dimension-reduction method, distinct immune
sub-populations were identified based on their variability in
genetic distribution patterns in the diseased aorta (Fig. 3a).
Screening for Ntn1 transcript within the clusters identified a
unique signature for Ntn1 among the heterogeneous immune
cells (Fig. 3b). Interestingly, amongst these hematopoietic clus-
ters, ~83% of the cells that expressed Ntn1 were macrophages
(Cd11b+/Cd68+/Adgre1+) while only ~7% of T cells (Cd3e+),
~5% of B cells (Cd19+), ~0.5% of neutrophils (Ly6g+), and ~3%
of dendritic cells (Itgax+) were detected as Ntn1 positive (Fig. 3c).
This was consistent with the mean level of Ntn1 transcript
abundance in each cluster which distinctly culminated in mac-
rophages (Fig. 3d). Double immunofluorescence staining of dis-
eased murine AAA sections confirmed the marked presence of
netrin-1 protein in CD68 positive macrophages (Fig. 3e, top) as
compared to PBS-infused mice (Supplementary Figure 1a).
Similar results were recapitulated in human sections (Fig. 3e,
bottom), further validating the data obtained by the single-cell
RNA-seq and emphasizing on the translational impact of
macrophage-dependent expression of netrin-1 in AAA. Tran-
scriptomic analysis of the macrophage cluster using the Loupe
Cell Browser software expanded the set of genes that best dis-
criminate the pools of Ntn1 positive macrophages within the
inflamed aortic vessel wall. Of note, we found that Ntn1 enriched
macrophages were those that highly expressed pro-inflammatory
markers and pro-angiogenic markers, while macrophages that
harbored lower levels of Ntn1 exhibited high anti-inflammatory
macrophage mannose receptor 1 mRNA (Mrc1) and anti-
atherogenic repertoire of genes consistent with previous
reports20,21 (Fig. 3f). Since macrophage mannose receptor 1
(CD206) is a recognized prototypical anti-inflammatory marker
of tissue macrophages, we performed laser capture microdissec-
tion of human AAA sections to selectively isolate either
CD68+CD206−or CD68+CD206+ segments of the tissue, as
previously described27. As shown in Fig. 3g, MRC1 transcript was
enriched in CD68+CD206+ segments captured from three
patients, while pro-inflammatory marker IL1B was only expressed
in CD68+CD206− samples, confirming the purity of the captured
aortic portions. Interestingly, NTN1 mRNA was increased in
CD68+CD206− clusters suggesting that, in vivo, macrophages
exhibiting pro-inflammatory phenotypes compatible with tissue
damage, were those where the expression of netrin-1 peaked,
indicative of a causative role of macrophage-derived netrin-1 in
AAA.
Netrin-1 deletion in macrophages inhibits AAA development.
To directly address the specific role of macrophage-derived
netrin-1 in AAA, mice harboring Ntn1 gene flanked by lox-P
sequences were bred with mice expressing the Cre recombinase in
mature macrophage lineage within the lysozyme C-2 gene Lyz2
(LysMcre) to generate Ntn1flox/floxLysMcre+/− (Ntn1−/−Mø)
and Ntn1flox/floxLysMcre-/- Nnt1l−/− (WTMø) control mice. No
phenotypic defects were observed in these mice and the reduced
expression of netrin-1 in monocytes/macrophages was verified
(Supplementary Figure 1b). Since the incidence of AAA is low in
the absence of hypercholesterolemia28 and in order to increase
the susceptibility of normocholesterolemic Ntn1−/−Mø and
WTMø C57BL/6 mice to AAA, we injected the mice with a single
dose of an adeno-associated virus (AAV) vector expressing the
D374Y gain-of-function proprotein convertase subtilisin/kexin
type 9 (PCSK9) that resulted in sustained hypercholesterolemia,
as described previously29. As shown in the schematic in Fig. 3h,
following either control or PCSK9 AAV injection, mice were
exposed to a western diet (WD) for 2 weeks before Ang II pump
was implanted for an additional 4 weeks, as previously descri-
bed30. Combined exposure of Ang II and PCSK9 AAV increased
the prevalence of AAA in WT Mø mice by a 4-fold factor com-
pared to mice exposed to control AAV and Ang II. Interestingly,
Ntn1−/− Mø mice were less susceptible to AAA when challenged
to control AAV in the presence of Ang II and only 20% that
received PCSK9 AAV in conjunction with Ang II developed
features of AAA, as depicted in the macroscopic images of the
renal region of the aorta (Fig. 3i). Aortic diameter revealed that
the aorta of WT Mø mice gradually expanded over time and
peaked at 28 days after treatment (Fig. 3j). The lack of netrin-1 in
macrophages protected mice from aortic enlargement similar to
healthy animals, consistently with preserved integrity of elastin
fibers (Fig. 3k) and reduced accumulation of inflammatory CD68
Fig. 2 Netrin-1 deficiency in hematopoietic lineage protects against AAA. Arterial pressure measurement (a), aneurysm prevalence (b), and severity
stratification (c) of WT→ApoE−/− and Ntn1−/−→ApoE−/− fetal liver chimeras exposed to Ang II for 0 or 28 days (n= 3–5 (a), n= 25 (b, c), *P < 0.05).
d Representative photomicrograph of aortas at sacrifice. Arrowhead indicates abdominal aneurysm. n= 6 for WT→ApoE−/− and n= 8 for Ntn1−/−
→ApoE−/−; scale bar 2 mm. Representative color Doppler ultrasound images of abdominal aortas at day 0 and day 28 in color mode (e) and in M-mode
(f) and measurements of maximum diameter at day 0 and 28 (arrows indicate vessel enlargement) n= 5; WT→ApoE−/− and n= 5; Ntn1−/−→ApoE−/−.
*P < 0.05. g mRNA levels of Adgre1 by quantitative PCR in aortas of WT→ApoE−/− (n= 8) and Ntn1−/−→ApoE−/− mice (n= 6). *P < 0.05.
h Representative immunofluorescence staining of macrophage marker CD68 (red) and nuclei (DAPI, blue); scale bar 50 µm; n= 3. i Example of elastin
staining (Verhoeff–Van Gieson staining). Red arrowheads indicate points of elastin breaks; scale bar 50 µm; n= 3. j Kaplan–Meier survival curves as
indicated. WT→ApoE−/−, n= 9; Nt1n−/−→ApoE−/−, n= 12. *P < 0.05. Unpaired, two-tailed t-test was used for statistical analysis in a, c, and g. Two-sided
Fisher’s exact test was used to compare variables in b. Two-way ANOVA was used in f. Statistical significance on Kaplan–Meier curves (j) has been
assessed with Mantel–Cox test. Data error bars represent s.e.m
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positive macrophages identified by immunohistochemistry
of serial aortic sections (Fig. 3l). Flow cytometry of diseased
aortic tissue confirmed the reduced accumulation of
CD45+/CD11b+/F4/80+ macrophages in the vascular wall of
Ntn1−/−Mø mice compared to WTMø (Fig. 3m). These results
were in line with the protective phenotype observed with
Ntn1−/−→ApoE−/− chimeras and clearly suggest that the
absence of netrin-1 in macrophages reduces the susceptibility
to develop AAA.
Netrin-1 regulates the activity of MMP3 in the vascular wall.
Since transcriptional mapping can provide key mechanistic
insights in an unbiased manner, we performed RNA-seq of aortas
isolated from WT→ApoE−/− and Ntn1−/−→ApoE−/− mice
exposed to Ang II to uncover the mechanisms underlying the
undefined role netrin-1 in AAA. Through this sensitive RNA
profiling of four individual aortas in each experimental group, we
generated a library of distinct transcriptome expression patterns
as revealed by the volcano plot (Supplementary Figure 2a). Uti-
lizing an adjusted nominal P value < 0.05, we designed a heatmap
representation that captured a large range of expression levels of
transcriptome imprints in AAA-prone compared to AAA-
protected groups (Fig. 4a). The consistency in the clustering
suggested a homogeneous genomic activity with limited back-
ground signal and high levels of reproducibility across the bio-
logical replicates in each group. Pathway analysis of this library
tracked significant and synchronized networks regulated by
netrin-1 in the vascular wall. Established functions of netrin-1
including axon development, apoptotic process and cytoskeleton-
dependent intracellular transport19–21,31 were highlighted
through software analysis (Supplementary Figure 2b) confirming
the robustness of the data. Compellingly, Mmp3, a key extra-
cellular matrix degrading enzyme catalyzing a broad range of
substrates with accessory inflammatory properties32,33, was
amongst the most significantly downregulated genes in the aortas
of Ntn1−/−→ApoE−/− mice (Fig. 4b-top). RT-PCR of a larger
experimental group validated the marked differential expression
of Mmp3 transcripts in diseased aortas (Fig. 4b-bottom). We
further established the downregulation of MMP3 protein
expression in Ntn1−/−→ApoE−/− aortic segments by immuno-
fluorescence, that revealed a significantly reduced expression of
MMP3 per section analyzed (Fig. 4c), in accordance with the
RNA-seq and RT-PCR results. Importantly, immunofluorescence
staining showed a strong decrease of MMP3 in aortic
sections isolated from Ntn1−/−Mø mice, that exhibited a dam-
pened susceptibility to develop AAA similar to
Ntn1−/−→ApoE−/− chimeric mice, compared to WT Mø aortic
sections (Fig. 4d). This was paralleled by decreased MMP3 cat-
alytic function in aorta isolated from Ntn1−/−Mø as opposed to
WTMø mice exposed to Ang II (Fig. 4e). These results clearly
evidenced that netrin-1 could fuel the expression of MMP3 with
potent ECM degrading capacity in the setting of AAA.
MMP3 activity promotes AAA. To investigate the direct role of
MMP3 in AAA, we challenged MMP3 deficient mice (Mmp3−/−)
to Ang II infusion prior to PCSK9 AAV injection. Blood pressure
was significantly increased in mice after 28 days of treatment
compared to the baseline measurements. No difference between
Mmp3−/− and WT mice blood pressure was observed at time of
sacrifice (Supplementary Figure 2c). Notably, MMP3 deficiency
substantially reduced both the incidence (Fig. 4f), the severity
(Fig. 4g) of AAA and aortic dilation (Fig. 4h) in comparison to
WT mice (Supplementary Figure 2d). Accordingly, extensive
elastin degradation was apparent in the vessel wall of WT mice
with active MMP3, while MMP3 deficiency maintained the
integrity of elastin fibers characterized by a reduction in elastin
degradation score (Fig. 4i). Altogether, our data demonstrate a
distinct aggravating role of MMP3 in AAA.
Macrophage-deficient MMP3 fail to rescue AAA. We further
characterized which cellular subsets were responsible for MMP3-
dependent AAA development. Because macrophages are impor-
tant sources of MMP3 in atherosclerotic lesions34, we performed
immunofluorescence to detect whether MMP3 was expressed by
macrophages harbored in AAA. MMP3 colocalized with
CD68 positive macrophages recruited in the diseased aorta
(Fig. 5a). We therefore assessed whether netrin-1 could regulate
MMP3 dynamics in macrophages. Recombinant netrin-1 indeed
dose-dependently increased MMP3 enzymatic activity in
bone marrow-derived macrophages (BMDMs) (Fig. 5b). To
assess the role of macrophage-derived MMP3 in vivo, we
reconstituted lethally irradiated WT recipient mice with either
WT or Mmp3−/− bone marrow cells to generate WT→WT and
Mmp3−/−→WT bone-marrow chimeras. After recovery, mice
were exposed to gain-of-function PCSK9 AAV prior to Ang II
infusion (Supplementary Figure 3a). Unexpectedly, we did not
observe any difference neither in the incidence nor in the
severity of AAA between WT→WT and Mmp3−/−→WT groups
(Fig. 5c, Supplementary Figure 3b). Similarly, although maximum
vessel diameter increased gradually weekly, no difference in
vessel enlargement was detected between WT→WT and
Mmp3−/−→WT groups (Fig. 5d). These data suggested that
although netrin-1 could induce the activity of MMP3 in
Fig. 3 Netrin-1 deletion in macrophages inhibits AAA development. t-distributed stochastic neighbor embedding (t-SNE) plot of single-cell RNA-
sequencing of diseased aortas (n= 3, pooled). Leukocyte clusters are color coded as shown (a), Ntn1mRNA distribution (log2) within the clusters (b). c Pie
chart showing percentage of Ntn1 mRNA per immune cell population. d Quantification of Ntn1 mRNA abundance per cell cluster. e Representative
immunofluorescence staining of CD68 and netrin-1 showing colocalization (merge; arrows) in aortic sections of Ang II mice (upper panels; scale bar 20 µm,
except left panel, scale bar 200 µm) and human aneurysmal tissue (lower panels; scale bar 20 µm, except left panel, scale bar 500 µm). Dashed boxes
indicate magnification sites displayed in right panels. Representative H&E staining of human section is shown. L lumen. n= 3. f Transcripts expression in
Ntn1 positive (right) and Ntn1 negative (left) macrophages. Genes are clustered according to biological process. gMRC1, IL1B, and NTN1mRNA expression in
human aneurysmal laser micro-dissected segments enriched in CD68+/CD206+ (n= 3) or CD68+/CD206− (n= 3) macrophages. Unpaired, two-tailed
t-test, *P < 0.05. h Schematic representation of PCSK9 (P) or control (C) adeno-associated virus vector (AAV) and Ang II treatments in C57BL/6J WT
(WTMø) and Ntn1fl/fl/LysM-Cre+/− (Ntn1−/−Mø) mice. WD western diet. Aneurysm prevalence with representative photomicrographs of aortas (i) (n=
15, WTMø/AAV P, n= 5 Ntn1−/− Mø/AAV P. Two-sided Fisher’s exact test; *P < 0.05. Red arrow indicates AAA) and aortic diameter (j) of WTMø and
Ntn1−/−Mø mice exposed to C or P AAV. (n= 4 mice; WT and Ntn1−/−Mø/AAV C), (n= 5; WT and Ntn1−/−Mø/AAV P). Two-way ANOVA, *P < 0.05.
k Microscopy images of elastin content (Verhoeff–Van Gieson staining) and elastin degradation score. Red arrowheads show elastin breaks. n= 3; scale
bar 50 µm; unpaired, two-tailed t-test, ***P < 0.001. l Representative aortic sections stained for CD68 macrophages; scale bar 50 µm. m Quantification of
macrophages (CD45+/CD11b+/F4/80+) by flow cytometry. n= 4; WT and Ntn1−/− Mø/AAV C), (n= 6; WT and Ntn1−/− Mø/AAV P). Unpaired, two-
tailed t-test, **P < 0.01. Error bars represent s.e.m
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macrophages in vitro, the deletion of MMP3 in the myeloid
lineage was insufficient to confer protection against AAA in vivo.
Vascular smooth muscle cell-derived MMP3 aggravates AAA.
Mmp3−/− mice were protected against AAA. Conversely, mice
with specific MMP3 deficiency in myeloid cells developed AAA.
We therefore speculated that MMP3 expression by resident
vascular cells within the arterial wall might contribute to the
development of AAA. Stimulation of endothelial cells or fibro-
blasts with increasing concentrations of recombinant netrin-1 did
not increase the activity of MMP3 (supplementary Figure 3e, f).
However, exposure of murine primary VSMCs to recombinant
netrin-1 significantly induced the enzymatic activity of MMP3 in
a dose-dependent way (Fig. 5e). Notably, the co-culture of acti-
vated WT macrophages with VSMCs in transwell assays
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promoted MMP3 activity in VSMCs. Similar assays in the pre-
sence of Ntn1−/− Mø abrogated MMP3 activity in VSMCs
(Fig. 5f). These data suggested that macrophage-derived netrin-1
could induce MMP3 activity in VSMCs. Interestingly, immuno-
fluorescence of AAA sections revealed a distinct MMP3 expres-
sion pattern in VSMCs (Fig. 5g). We henceforth investigated
whether VSMCs-derived MMP3 could contribute to the patho-
genesis of AAA. Since no MMP3 conditional mice is commer-
cially available, we reconstituted MMP3−/− recipient mice with
bone marrow cells isolated from WT mice to generate
WT→Mmp3−/− or WT→WT chimeras in order to delete
MMP3 only in cells from non-hematopoietic origin, including
VSMCs. After bone marrow transplantation recovery period,
WT→Mmp3−/− and control WT→WT mice were exposed to
gain-of-function PCSK9 AAV prior to Ang II infusion. The
absence of MMP3 in stromal compartment completely protected
WT→Mmp3−/− animals from developing AAA compared to
WT→WT mice (Fig. 5h) albeit no difference in systemic blood
pressure (Supplementary Figure 3c). WT→Mmp3−/− exhibited
mild stages of the disease in agreement with reduced aortic
enlargement (Fig. 5i) (Supplementary Figure 3d). The aortic
diameter was also significantly reduced in WT→Mmp3−/−mice
as opposed to WT→WT littermates (Fig. 5j). Consistent with
these observations, the deletion of MMP3 in the stromal com-
partment preserved healthy elastin fibers (Fig. 5k). Altogether,
our data point out to the instrumental role of macrophage-
derived netrin-1 in driving MMP3 catalytic activity in VSMCs.
Netrin-1 fine tunes calcium influx to activate MMP3 in
VSMCs. We further delved into the molecular mechanisms reg-
ulating netrin-1-dependent effects on MMP3 in VSMCs. The
decoding of the sequenced RNA-Seq library through pathway
enrichment predicted a crosstalk between netrin-1 and calcium
signaling in conjunction with MMP3 expression (Supplementary
Figure 2b). Notably, calcium (Ca2+) is a critical co-factor
necessary for the activation of the catalytic subunit of MMP335.
Because excessive secretion of extracellular matrix degrading
enzyme can be due to intracellular accumulation of Ca2+,
we questioned whether netrin-1 could impact the availability of
Ca2+. We found that netrin-1 potently and rapidly induced an
intracellular Ca2+ wave in VSMCs as tracked by excitation
emitted by the Ca2+-sensitive FURA-2-fluorescent dye (Fig. 6a).
Similar experiments in the presence of Ca2+-free media abro-
gated the boost of intracellular Ca2+ suggesting that exogenous
netrin-1 could regulate the mobilization of extracellular pools of
Ca2+. Accordingly, stimulation of VSMCs with netrin-1 in the
presence of the Ca2+ chelator, 1,2-bis(o-aminophenoxy) ethane
-N,N,N′,N′-tetraacetic acid (BAPTA) blunted the induction of
MMP3 activity (Fig. 6b). Immunofluorescence of murine and
human VSMCs following netrin-1 stimulation revealed the
nuclear translocation of NFATc3, a transcription factor pre-
viously described to regulate MMP3 expression in astrocytes35.
The staining pattern was reversed in the presence of BAPTA
suggesting that netrin-1-induced NFATc3 nuclear translocation is
dependent on Ca2+ (Fig. 6c). Importantly, netrin-1-induced
MMP3 catalytic activity was totally abrogated in the presence of
NFATc3 inhibitor, MAGPHPVIVITGPHEE (VIVIT) peptide
(Fig. 6d). Altogether these findings suggested the central role for
netrin-1 in driving MMP3 activity by synchronizing Ca2+ sig-
naling in VSMCs.
Netrin-1 regulates MMP3 via its receptor neogenin-1 in
VSMCs. We have previously demonstrated that neogenin-1 is the
primary receptor for netrin-1 expressed by VSMCs21. Here, we
tested whether netrin-1 could regulate MMP3 expression via
neogenin-1. Immunoflurescence staining revealed a colocalized
expression of neogenin-1 and VSMCs in murine aortic sections
(Fig. 6e). MMP3 activity was increased in VSMCs stimulated with
recombinant netrin-1 but not in cells pretreated with anti-
neogenin-1 blocking antibody. The exposure of VSMCs to anti-
Unc5b, another reported receptor of netrin-1, did not abrogate
netrin-1-induced MMP3 activity compared to cells exposed to
IgG control (Fig. 6f). We validated these results by a second
method of neogenin-1 invalidation by siRNA-mediated approach.
Stimulation of VSMCs with recombinant netrin-1 induced the
activity of MMP3 in VSMCs exposed to non-targeting scrambled
siRNA (siRNA control) while the silencing of neogenin-1, not
Unc5b, abrogated the activity of MMP3 in the presence of
recombinant netrin-1 (Fig. 6g). These data suggested that the
selective activation of neogenin-1 by netrin-1 triggers signaling
cascades required to activate MMP3. Notably, netrin-1-induced
intracellular Ca2+ wave in VSMCs was blunted in VSMCs
exposed to anti-neogenin-1 blocking antibody (Fig. 6h). The
nuclear translocation of the transcription factor NFATc3 induced
by netrin-1 was refrained in cells exposed to neogenin-1 blocking
antibodies (Fig. 6i). To demonstrate that macrophage-derived
netrin-1 could regulate MMP3 via neogenin-1 in VSMCs, we
performed co-culture assays between macrophages and VSMCs
in transwells. MMP3 activity was increased in VSMCs co-
cultured with activated macrophages, while it was significantly
reduced in VSMCs exposed to anti-neogenin-1 blocking antibody
(Fig. 6j). Taken together, we have identified that netrin-1 secreted
by macrophages can act as a central catalyzer of MMP3 activity
via neogenin-1 activation in VSMCs.
Discussion
Our results have uncovered dynamic mechanisms that bridge
sustained inflammation and focal ECM erosion in the AAA sac
and identified netrin-1 as an instrumental signal in perpetuating
this destructive response as illustrated in the supplementary
schematic (Supplementary Figure 4).
Netrin-1 regulated intracellular calcium flux in VSMCs. This
finding has not yet been described and is important as calcium is
a key cofactor necessary to maintain cellular homeostasis36,37 in
the vascular wall. This is in accordance with studies that initially
Fig. 4 Netrin-1 regulates MMP3 activity in AAA. a Heatmap representation of transcriptomic profiling of WT→ApoE−/− and Ntn1−/−→ApoE−/− aorta by
RNA-sequencing (RNA-seq). n= 4 per group. b Mmp3 mRNA copy numbers identified by RNA-seq (n= 4 per group) and quantitative PCR analysis of
Mmp3 transcript in aortas (n= 8; WT→ApoE−/−, n= 6; Ntn1−/−→ApoE−/−). *P < 0.05. Representative immunofluorescence staining and quantification of
MMP3 in aortic sections of WT→ApoE−/− and Ntn1−/−→ApoE−/− (c) and WTMø and Ntn1−/−Mø (d) (n= 3 per group); upper panels, scale bar 200 µm.
Bottom panels (scale bar 20 µm) show magnified region of dashed box. *P < 0.05 (e) MMP3 catalytic activity assay in aortic lysates of PBS infused WT,
WTMø and Ntn1−/−Mø (n= 4 per group) mice treated with Ang II. *P < 0.05, **P < 0.01. Aneurysm prevalence (f), severity stratification (g), and aortic
enlargement (h) of WT (n= 6) and MMP3 whole body-deficient mice (Mmp3−/−) (n= 7) exposed to Ang II. *P < 0.05, **P < 0.01. i Representative image
of elastin (Verhoeff–Van Gieson staining) and degradation scored in the aortic media. Red arrowheads indicate elastin rupture. Scale bar 100 µm; n= 3 per
group. *P < 0.05. Unpaired, two-tailed t-test was used for statistical analysis in b–e, g, and i. Two-sided Fisher’s exact test was used to compare variables in
f. Two-way ANOVA was used in h. Data error bars represent s.e.m
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uncovered the role of netrin-1 in the neuronal system38. Notably,
netrin-1 could induce calcium by mobilizing intracellular stores, a
mechanism required for axonal branching39. Despite that some
reports have evoked aberrant calcium signaling in AAA, the
direct role of calcium in the focal activation of MMP3 was
undescribed so far. Our data provide evidence that netrin-1 can
direct the extracellular calcium influx into VSMCs as calcium
measurements performed in the presence of calcium-free media
completely blunted netrin-1-induced signal. Interestingly, aber-
rant calcium regulation which leads to calcium depots has been
described to be causative in vascular diseases such as athero-
sclerosis40 and Marfan syndrome41. In the latter, extensive elastin
fragmentation was shown to manifest in areas enriched in
microcalcification42. Future studies are required to uncover the
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exact molecular signaling pathways through which netrin-1 can
exert such effects on the import of calcium in cells. Notably, it is
likely that netrin-1 could synchronize intracellular pools of cal-
cium that might orchestrate VSMCs function in a broad spec-
trum. Interestingly, emerging reports have described the plasticity
of VSMCs within injured aortic tissues43. VSMCs can deviate
from their original contractile phenotype and adopt a
macrophage-like secretory hybrid role. This is tightly dependent
on the microenvironment. VSMCs can also inherit enhanced
contractile potential such as those isolated from mice with
Marfan syndrome44. Our results indicate that the exposure of
VSMCs to netrin-1, robustly drive calcium signaling critical for
the proteolytic activity of MMP3.
Consistent with other studies, increased MMP3 expression has
been described in AAA45. Elevated levels of MMP3 can be
attributable in part to the influx of activated inflammatory cells
including monocytes/macrophages within the aneurysmal tis-
sue46. Depletion of these phagocytic cells dampened enzymatic
activities in the diseased portion of the aorta18,47. Our results
demonstrate that netrin-1 induced MMP3 activity specifically in
VSMCs but not in endothelial cells nor in fibroblasts. This can be
explained by the uneven distribution of the receptor of netrin-1,
neogenin-1 in vascular cells. As such, our data indicate that the
activation of neogenin-1 expressed by VSMCs leads to intracel-
lular Ca2+/NFATc3 mobilization responsible to regulate MMP3
catalytic activity. Furthermore, besides MMP3 uncontrolled cat-
alytic activity in AAA, independent studies have uncovered that
the gene encoding MMP3 bears a functional polymorphism
characterized by adenosine number (5A/6A) in the promoter
region48,49 and represent independent risk factors for AAA50,
further emphasizing the involvement of this enzyme in the
pathogenesis of AAA. However, the direct role of MMP3 in AAA
was not addressed so far in the gold-standard Ang II-infused
murine model. Amidst the investigation of the role of MMP3 in
atherosclerosis, Lijnen et al showed that the deletion of MMP3 in
ApoE−/− mice exposed to high cholesterol diet reduced features
of aortic damage, but did not protect against lesion develop-
ment51. These findings are in agreement with our results
demonstrating that the deletion of MMP3 in AAA-prone mice
reduced arterial damage associated with AAA development.
The current dogma generally supports the paradigm that
inflammatory cells might contribute to AAA by promoting the
exaggerated activity of MMPs causative of significant vascular
injury precipitating to aortic expansion and rupture18. However,
the role of these enzymes was studied secondary to the manip-
ulation of immune subsets shadowing the contribution of other
stromal cells within the AAA sac. Notably, recent concepts
depicting the role of MMPs in directing inflammatory signals
have emerged52–54 suggesting that vascular cells producing
MMPs might also impact local inflammation. Our data surmise
that macrophages synergize with VSMCs to shape ECM break-
down unrestrictedly most likely by obstructing mechanisms
responsible for the repair of ECM. Noteworthy, pharmacological
suppression of MMPs such as doxycycline therapies resulted not
only in reduced aortic MMP3 expression but also dampened the
inflammatory response in a clinical cohort55 raising the question
of whether the contribution of inflammation to AAA is secondary
to vascular injury or whether it is the origin of sequences that
converge to damage in AAA. Interestingly, in experimental
models of AAA, doxycycline administration failed to refrain the
progression of established AAA56 suggesting that additional
factors contribute to the initiation of the disease. Our data pro-
vide insights of how macrophages that invade AAA leave an
imprint of their presence within the arterial scar which is cau-
sative to the timely and sustained activation of MMP3. This is
strongly supported by our results demonstrating that the absence
of MMP3 in macrophages is insufficient to protect against AAA
in contrast to the impact of netrin-1 deficiency in macrophages.
However, our in vitro data supported that netrin-1 could direct
MMP3 activity in macrophages. While the reasons for these
discrepant findings are unclear, they may be explained because in
Mmp3−/−→WT bone-marrow chimeras, VSMCs might com-
pensate for the loss of MMP3 in macrophages henceforth
masking the protective effect of macrophage-derived MMP3 in
Mmp3−/−→WT bone-marrow chimeras. Furthermore, MMP3
can act as an upstream activator of other MMP isoforms
including MMP957,58. Interestingly, studies have highlighted the
deleterious role of macrophage-derived MMP9 in AAA59,60.
Therefore, MMP3 produced by VSMCs could contribute to
enhance macrophage-induced ECM degradation even though the
latter are refractory to MMP3 expression. We can therefore
speculate that macrophages recruited to the site of aortic trauma
might serve as an initial damage trigger which eventually per-
petuates into chronic MMP3 catalytic signals following VSMCs
activation by netrin-1.
Taken together, our study provides important mechanistic
evidence of how macrophage-derived netrin-1 can impact focal
MMP3 activation. We anticipate that interventions to disrupt
such crosstalks might be the cornerstone of therapeutic strategies
for future drug development in the setting of AAA.
Methods
Mice. C57BL/6J (WT), LysMcre and ApoE−/− mice were purchased from Jackson
Laboratories. Ntn1+/−mice were bred with ApoE−/− to generate Ntn1+/+ApoE−/−
and Ntn1−/−ApoE−/− donors. Fetal liver cells (2 × 106) from donor mice were
injected intravenously into 6−week-old recipient ApoE−/− mice that were lethally
irradiated (two exposures of 600 cGy) followed by antibiotic treatment. Recon-
stituted mice were allowed to recover for 6 weeks before experimentation. LysMcre
+/− mice were bred with Ntn1flox/flox mice (provided by Dr. Holger Eltzschig) to
generate LysMcre+/−Ntn1flox/flox mice to delete Ntn1 in LysMcre positive lineage.
Ntn1flox/flox littermates were used as experimental controls. MMP3-deficient
(Mmp3−/−) mice on C57BL/6J background were purchased from Taconic
Fig. 5 MMP3 contributes to AAA. a Representative immunofluorescence staining of CD68, MMP3 and their colocalization (merge, yellow) in ApoE−/−
mice aneurysmal aortic sections. Dashed box represents magnified area. Nuclei stained with DAPI (blue); scale bar 50 µm, except for left panel, scale bar
200 µm. b Quantification of MMP3 enzymatic activity in BMDMs stimulated with recombinant netrin-1 (left to right: 0.625, 1.25, and 2.5 µg/ml) for 6 h. n
= 7. *P < 0.05, ***P < 0.001. Aneurysm prevalence (c) and aortic diameter (d) of bone marrow transplant WT→WT and Mmp3−/−→WT chimeras. MMP3
enzymatic activity in VSMCs stimulated with recombinant netrin-1 (e) (left to right: 0.625, 1.25, and 2.5 µg/ml, n= 7 per group) or cultured in presence or
absence of WTMø (blue) or Ntn1−/−Mø (red) (f) (n= 6 per group). *P < 0.05, **P < 0.01. g Immunofluorescence staining of MMP3 (red) and alpha-
smooth muscle actin (SMA, green) in aortic sections of ApoE−/−mice infused with PBS or Ang II. Colocalization is shown in merge (yellow). Nuclei stained
with DAPI (blue). Scale bar 50 µm. Aneurysm prevalence (h), severity stratification (i) (WT→WT, n= 13 and WT→Mmp3−/−, n= 4. *P < 0.05) and aortic
diameter (j) of WT→WT (n= 7) and WT→Mmp3−/− (n= 4) chimeras. *P < 0.05. k Elastin content (Verhoeff–Van Gieson staining) and degradation
score. Red arrowheads indicate points of elastin rupture. Scale bar 100 µm. n= 3 per group. *P < 0.05. One-way ANOVA was used to assess statistical
significance in b and e. Two-sided Fisher’s exact test was used to compare variables in c and h. Data in d and j were analyzed by two-way ANOVA.
Unpaired, two-tailed t-test was used for statistical analysis in f, i, and k. Error bars represent s.e.m
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Biosciences. Lethally irradiated C57BL/6 J mice were reconstituted with either
C57BL/6J or Mmp3−/− bone marrow cells following lethal irradiation to generate
WT→WT and Mmp3−/−→WT chimeras. For stromal deletion of MMP3 studies,
Mmp3−/− mice were used as recipient and transplanted with bone marrow cells
from C57BL/6J to generate WT→Mmp3−/− chimeras. All mice were maintained in
a pathogen-free facility. C57BL/6J mice were fed a standard chow or Western diet
(WD; 21% [wt/wt] fat, 0.3% cholesterol; Research Diets). When applicable, mice
were distributed randomly in each group and sample size has not been pre-
determined by statistical method. Mice dying before sacrifice with no signs of aortic
pathology were excluded from the analyses. Experimental procedures were
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approved and completed in accordance with guidelines set forth in the US
Department of Agriculture Animal Welfare Act, the Public Health Service Policy
for the Humane Care and Use of Laboratory Animals and the New York University
School of Medicine’s Institutional Animal Care and Use Committee.
Human samples. The studies were approved and conducted in accordance with
policies of the New York University Langone Medical Center Institutional Review
Board. Informed consent was obtained for each subject. Samples of unruptured
human aneurysmal (>50 mm) aortic wall were collected during open aortic repair
procedures. After orientation of the tissue following macroscopic analysis, samples
were formalin-fixed and paraffin-embedded prior to sectioning. For laser capture
microdissection, frozen serial sections were stained for CD68 and CD206 to
identify CD68+CD206− and CD68+CD206+ macrophage regions, respectively.
CD68+CD206− and CD68+CD206+ enriched unstained 18 µm sections were
isolated from the appropriate areas on CapSure Macro LCM Caps using an Arc-
turusXT Microdissection Instrument (MDS Analytical Technologies) and pro-
cessed immediately for RNA extraction with the PicoPure RNA Extraction Kit
(KIT0204, MDS Analytical Technologies). RNA integrity was checked on an
Agilent 2100 Bioanalyzer (Agilent Technologies) with RNA Pico Chips (Agilent
Technologies) and amplified 2 rounds through the ExpressArt Trinucleotide
mRNA amplification Nano Kit (7299-A15, AMS-Biotechnology) before retro-
transcription27.
AAA induction in mice. Alzet osmotic pumps (model 2004; 0000298, Durect
Corporation) were loaded with PBS or angiotensin II (H-1705, Bachem) and
implanted subcutaneously for a delivery rate of 1 μg/kg/min for 28 days as pre-
viously described15. Blood pressure was monitored weekly by tail cuff using the
CODA machine (Kent Scientific Corporation), and aneurysm progression was
assessed by ultrasound Doppler imaging. At sacrifice, macroscopic evaluation of
the aorta was used to grade the severity of AAA26. Enlarged aorta without
thrombus and dilated aorta that frequently contained thrombus was scored as
stages I and II, respectively. Stage III categories included bulbous aortas with visible
thrombus and stage IV was defined as multiple aneurysmal containing thrombus.
Prior to aneurysm induction, 6–8-week-old mice were injected with 1011 genomic
copies of either PCSK9 or control AAV based on the study of Daugherty et al.30
and fed a Western diet as described above until sacrifice.
Ultrasound imaging. A Vevo 2100 ultrasound imaging platform (FUJIFILM
VisualSonics) was utilized throughout the study. After sedation, mice were placed
on a heating pad and kept on sedation throughout the procedure. Body tem-
perature and cardiac pace were monitored. Mice were placed on an electric-heated
blanket to maintain normothermia and continuously delivered a gas inhalation of
two percent isoflurane. Heart rate was monitored throughout image acquisition
and kept at a consistent range (400–500 beats per minute) as previously descri-
bed61–63, and provided reproducible results for all experimental groups. Mice
abdomen were shaved and Aquasonic 100 ultrasound transmission gel
(NC9861677, Parker Laboratories) was added to increase probe contact. All images
were acquired using the settings provided by the manufacturer. The probe was first
applied on short axis to locate the aorta, and the pulsatile property of the vessel was
used to distinguish from the vena cava (PW mode). The aorta was then centered
and the probe switched to the long axis. Color mode Doppler was then activated to
help localize the two renal arteries, displaying a red blood flow toward the probe on
the screen. The probe was moved until the aorta was strictly parallel to the device
in order to acquire measurements of the aortic diameter. Three measurements were
performed by a blinded investigator on the long axis (M mode): above the upper
renal artery, on maximal aortic dilation, and below the lower renal artery. Data for
the maximal transverse aortic diameter is shown for individual animals.
RNA sequencing. RNA was extracted from aortas using the RNEasy fibrous tissue
kit as per manufacturer’s instructions (74704, Qiagen). RNA quality was verified
using a Bioanalyzer (G2939BA, Agilent Technologies). The samples were run on a
HiSeq (Illumina) as single-end reads, 50 nucleotides in length. FASTQ files were
aligned to the MM9 Mus musculus reference genome using Tophat (version 2.0.9)
with two mismatches allowed. The resulting read counts were extracted using the
Featurecounts program from binary alignment map (BAM) files. Differential gene
expression analysis was conducted using the DESEQ2 package from the Bio-
conductor repository using the open source R statistical programming environ-
ment. All downstream data manipulation, plotting, and statistical filtering were also
performed in the same environment using custom scripts. P values attained from
differential gene expression analysis were adjusted for multiple testing by con-
trolling for false discovery using the Benjamini-Hochberg method and genes with
adjusted P values < 0.05 were flagged as differentially expressed then used for Gene
Set Enrichment Analysis (GSEA). GSEA was performed using the DAVID Bioin-
formatics Resource (version 6.8) to elucidate relevant biological significance.
Single-cell RNA-sequencing. Aortas were collected and digested for 1 h at 37 °C
in an enzymatic mix (10 mg/ml Collagenase type II (C6885, Sigma Aldrich) and 1
mg/ml Elastase (LS002292, Worthington Biochemistry). Digested aortas were
mechanically disrupted and immediately processed for single-cell RNA-sequen-
cing. The cellular suspensions were loaded on a 10x Genomics Chromium
instrument to generate single cell gel beads in emulsion (GEMs). Libraries were
prepared using the following kits: Chromium Single Cell 3′ Library & Gel Bead Kit
v2, PN-120237; Single Cell 3′ Chip Kit v2 PN-120236 and i7 Multiplex Kit PN-
120262, 10x Genomics) as described64. Sequencing was performed on an Illumina
HiSeq 4000 as 2 x 150 paired-end reads, one full lane per sample, for approximately
>90% sequencing saturation. For alignment, barcode assignment and unique
molecular identifiers (UMI) counting, the Cell Ranger Single Cell Software Suite,
version 1.3 was used to perform sample de-multiplexing, barcode and UMI pro-
cessing, and single-cell 3′ gene counting (https://support.10xgenomics.com/single-
cell-gene). Data analysis was performed using the Loupe Cell Browser software
(10x Genomics) on Cloupe files displaying tSNE projections of cell transcriptome.
Cell types were identified by their expression levels of gene provided that at least
two copies of the transcript were found in the cell (cutoff: log2 fold-increased
copies= 1 vs 1 copy only per cell) (Supplementary Table 1). Loupe Cell Browser
was then used to compare the transcriptome of each identified cluster corrected for
false discovery rates, as applied in RNA sequencing. The expression of transcripts
within macrophage clusters identified as Ntn-1 positive or negative subclusters are
provided in supplementary Table 2.
Real-time quantitative PCR. Samples were homogenized in TRIzol reagent
(15596026, Ambion, Life Technologies) and mRNA was extracted using a Direct-
zol RNA MiniPrep Kit (R2052, Zymo Research). Retro-transcription in cDNA was
performed with the iScript cDNA Synthesis Kit (1708890, Bio-Rad). Quantitative
real-time PCR was then carried out with KAPA SYBR FAST qPCR Kits (KK4602,
KAPA Biosystems) on a QuantStudio 3 Real-Time PCR System (Applied Biosys-
tems) in triplicates. Results were analyzed and fold change over housekeeping gene
were calculated by the comparative cycle method (2−ΔΔCt).
Primer sequences used:
Mouse 28S: F TGGGAATGCAGCCCAAG, R
CCTTACGGTACTTGTTGACTATCG
Mouse Ntn1: F CAGCCTGATCCTTGCTCGG, R
GCGGGTTATTGAGGTCGGTG
Mouse Adgre1: F CCCCAGTGTCCTTACAGAGTG, R
GTGCCCAGAGTGGATGTCT
Mouse Ccl2: F TTAAAAACCTTGGATCGGAACCAA, R
GCATTAGCTTCAGATTTACGGGT
Fig. 6 Netrin-1 mobilizes Ca2+ and drives MMP3 activity in vascular smooth muscle cells via its receptor neogenin-1. a Calcium integration curves in
VSMCs stimulation as indicated. Data are expressed as 340/380 nm excitation ratio. n= 4. *P < 0.05. bMMP3 activity in murine VSMCs stimulated with
netrin-1 in the presence or absence of calcium chelator BAPTA (10 µM). n= 6–7 per group. **P < 0.01. c NFATc3 (green) and actin (F-actin, red)
immunofluorescence staining in mouse VSMCs (top panel) or human VSMCs (lower panel) stimulated with netrin-1 (2.5 µg/ml) with or without BAPTA.
White arrowheads indicate nuclear location, n= 4. Scale bars 20 µm. d MMP3 activity in mouse VSMCs stimulated with netrin-1 in the presence or
absence of NFATc3 inhibitor, VIVIT (1 µM). n= 6–7 per group. ***P < 0.001. e Immunofluorescence staining of neogenin-1 (NEO-1, red) and alpha-smooth
muscle actin (SMA, green) in aortic sections of ApoE−/− mice. Colocalization is shown in merge. Nuclei stained with DAPI (blue). Scale bar 50 µm. f
MMP3 activity in VSMCs stimulated with recombinant netrin-1 in the presence of control IgG, anti-NEO1, or anti-UNC5B neutralizing antibody (10 µg/ml).
n= 6 per group. *P < 0.05, NS not significant. gMMP3 activity in VSMCs transfected with siRNA control, Neo1 or Unc5b and stimulated with recombinant
netrin-1. n= 4–9 per group. *P < 0.05, **P < 0.01, NS= not significant. h Calcium integration curves in VSMCs stimulated as indicated. Data are expressed
as 340/380 nm excitation ratio. *P < 0.05. i NFATc3 and F-actin immunofluorescence staining of VSMCs stimulated with netrin-1, in the presence of
control IgG or anti-NEO1 blocking antibody. White arrowheads indicate nuclear translocations. Scale bar 20 µm. j MMP3 enzymatic activity in VSMCs co-
cultured with WTMø in the presence of control IgG or anti-NEO1 antibody. n= 4–8 per group. *P < 0.05. Two-way ANOVA was used to assess statistical
significance in a and h. Unpaired, two-tailed t-test was used for statistical analysis in b, d, f, g, and j. Error bars represent s.e.m
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Mouse Il6: F CCAAGAGGTGAGTGCTTCCC, R
CTGTTGTTCAGACTCTCTCCCT
Mouse Mmp3: F GTCCCTCTATGGAACTCCCAC, R
AGTCCTGAGAGATTTGCGCC
Human 28S: F TGGGAATGCAGCCCAAG, R
CCTTACGGTACTTGTTGACTATCG
Human MRC1: F CGAGGAAGAGGTTCGGTTCAC C, R
GCAATCCCGGTTCTCATGGC
Human IL1B: F AGCTCGCCAGTGAAATGATGG, R
CAGGTCCTGGAAGGAGCACTTC
Human NTN1: F ACAACCCGCACAACCTGAC, R
GGGACAGTGTGAGCGTGAC
Cell culture. Mice femurs and tibias were collected and the bone marrow was
flushed and differentiated into primary BMDMs. Cells were cultured for 7 days in
DMEM (MT10013CV, Fisher Scientific) supplemented with 10% Fetal Bovine
Serum (FBS; 10082147, Life Technologies),1% penicillin–streptomycin (PS; 30-002-
CI, Corning) and 20% L-929-conditioned media. After differentiation, BMDMs
were stimulated as indicated in results. Mouse primary vascular smooth muscle
cells (VSMCs) were isolated from the descending section of freshly dissected aortas.
After dissection and removal of the peri-adventitial fat, aortic samples were
digested for 10 min at 37 °C in enzymatic mix (10 mg/ml type II collagenase,
C6885, Sigma Aldrich and 1 mg/ml elastase, LS002292, Worthington Biochem-
istry). The adventitia was gently removed under a dissecting microscope and the
remaining tissue was digested for 50 additional minutes in the enzymatic mix.
Digested aortas were then mechanically disrupted and passed through a 70 µm cell
strainer (340607, BD Biosciences). Cells were then cultured in DMEM-10%FBS-1%
PS and used for experiments as previously described65. VSMCs lineage was con-
firmed by the presence of immunoreactivity for α-actin by flow cytometry (Alexa
Fluor 405 anti-alpha smooth muscle actin; ab210128, Abcam). Human primary
vascular smooth muscle cells (CRL-1999TM, ATCC) and mouse embryonic fibro-
blasts (CRL-2991TM, ATCC), were purchased from the American Type Culture
Collection and cultured according to manufacturer’s instruction. For subculturing,
mycoplasma contamination was tested by a commercially available kit (M7006,
Invitrogen) as per the manufacturer’s instructions.
Pharmacological inhibitors, VIVIT (MAGPHPVIVITGPHEE peptide, #3905,
Tocris Biosciences) or BAPTA (B1205, Invitrogen), were added 30 min prior
netrin-1 stimulation. In some assays, neutralizing antibodies, goat anti-neogenin-1
antibody (AF1079-SP, R&D Systems), goat anti-Unc5b antibody (AF1006-SP, R&D
Systems) or goat IgG control (AB-108-C, R&D Systems) were added 30 min prior
to stimulations. To ensure reproducibility, three technical replicates were
performed each time on at least two biologically different cell lines.
For co-culture experiments, BMDMs from WT or Ntn1flox/floxLysMcre+/−
Ntn1 mice (105 cells) were cultivated on top chamber of transwell inserts, in 200 µl
DMEM 2% FBS. Mouse WT VSMC were seeded in the lower chamber of Corning™
Transwell™ Multiple Well Plate with Permeable Polycarbonate Membrane Inserts
(07-200-147, ThermoFisher), 105 cells/well in 500 µl DMEM 10% FBS, and allowed
to adhere overnight. BMDM/VSMC were then co-cultured for 24 h and VSMC
were lysed in 50 µl RIPA buffer (without protease inhibitor) and assayed for Mmp3
activity.
To knock down neogenin-1 and Unc5b, VSMCs were transfected with siRNA
targeting neogenin-1 (Neo 1 siRNA SASI_Mm02_00291095, Sigma Aldrich) or
Unc5b (E-050737-00-0005, Dharmacon, SMARTpool) using siRNA reagent system
(sc-45064, Santacruz Biotechnology) as per manufacturers’ instructions. A non-
targeting siRNA-scrambled sequence was as control (SC-37007, Santacruz
Biotechnology).
MMP3 activity assay. MMP3 activity in cells and homogenized aortic tissue was
assessed using the MMP3 Activity Fluorimetric Assay Kit (K783–100, Biovision),
following the manufacturer’s instruction. Data were expressed as the amount of
enzyme generating 1 µmol of fluorescent substrate per minute per milliliter of
sample (nmol/min/ml).
Flow cytometry. Aortic cell suspensions were prepared as described above.
Digested aortas were then mechanically disrupted and passed through a 70 µm cell
strainer (340607, BD Bioscience), centrifuged 10 min at 1000 × g at room tem-
perature and fixed in 300 µl PBS-2%PFA before further staining. A volume of 50 µl
of aortic cell suspension was then stained for 20 min with an antibody mix con-
sisting of VioGreenTM anti-CD45 (130-102-412, Miltenyi biotechnology) PE-
Vio770 anti-F4/80 (130-102-193, Miltenyi biotechnology) and APC anti-CD11b
(130-091-241, Miltenyi biotechnology), 1:50 dilution each, resuspended in 500 µl of
PBS-1%PFA, ran on a BD LSRII flow cytometer (Becton Dickinson) recorded using
the FACSDiva software (Becton Dickinson) and acquired data were analyzed using
the FlowJo software (FlowJo, LLC). Doublets were excluded on a FSC-A/FSC-H dot
plots. Leukocyte population, which served as a stopping gate (5000 events recorded
in the stopping gate), was identified as CD45 positive cells on a FSC-A/CD45 dot
plots. Macrophage population within leukocytes was identified as a CD11b+F4/80+
populations on a CD11b/F4/80 plots (on average, 500 (for the PBS-infused mice) to
2500 (for the Ang II-infused mice) macrophages were recorded).
Immunohistochemical staining. Mice aortas were included in Optimal Cutting
Temperature Compound (OCT; 4585, Fisher Scientific) and 7-µm-thick sections
were cut and fixed with 10% formalin buffer. Human paraffin-embedded aortas
sections were deparaffinized and rehydrated by successive washes of xylene, xylene/
ethanol (vol/vol), 100% ethanol, 95% ethanol, 70% ethanol and water. Antigen
retrieval was performed by boiling in 10 mM Tris, 1 mM EDTA, 0.05% Tween20,
pH9 retrieval buffer. Sections were then blocked before overnight incubation of
primary antibodies: chicken anti-Mouse/human netrin-1 (ab39370, Abcam), rat
anti-Mouse CD68 (MCA1957, Bio-Rad), mouse anti-Human CD68 (MCA5709,
Bio-Rad), rabbit anti-mouse/human MMP3 (ab53015, Abcam), goat anti -mouse
neogenin-1 (AF1079, R&D Systems) or anti-mouse alpha-smooth muscle actin
(ab7817, Abcam) (1:500 dilution each). Secondary fluorescent antibodies (Alexa
Fluor 488 goat anti-mouse, A11001, Alexa Fluor 568 goat anti-mouse, A11004,
Alexa Fluor 488 goat anti-rabbit, A11008, Alexa Fluor 568 goat anti-rabbit,
A11011, Alexa Fluor 568 goat anti-rat, A11077, Alexa Fluor 568 donkey anti-goat,
A-11057, Alexa Fluor 488 goat anti-chicken, A11039, 1:400 dilution each, Invi-
trogen) were then applied for detection. VSMCs were seeded directly on Lab-Tek
chamber slides (154534, Thermo Fisher Scientific), 5 × 105 cells/well in complete
DMEM. Following netrin-1 (1109-N1, R&D Systems) stimulation (2.5 µg/ml), cells
were fixed in ice-cold 2% buffered formalin, blocked and permeabilized before
incubation with primary mouse anti-NFATc3 antibody (1:200 dilution; SC-8405,
Santa Cruz Biotechnology). Secondary fluorescent Alexa-Fluor 488 goat anti-
mouse antibody (1:500 dilution; A11001, Invitrogen) was then applied for detec-
tion. 4′,6-diamidino-2-phénylindole (DAPI, 1: 50,000; D1306, Invitrogen) was used
for cell nucleus staining. Alexa-Fluor 568 phalloidin (1:40 dilution; A12380, Invi-
trogen) was used to stain actin cytoskeleton. Images were acquired using a Zeiss
LSM 700 confocal microscope (Carl Zeiss) through the Zeiss Efficient Navigation
(ZEN) software (Carl Zeiss). Identical acquisition parameters were set to capture
control and test samples. Quantifications were performed on sections from three
different animals without any prior setting modification. Levels of brightness and
contrast were adjusted following identical modifications within each experiment.
Scale bars are indicated on respective magnified images for each experiment.
For histochemical assays, 7 µm mice aortic sections included in OCT were
stained for elastin figments using the Verhoeff Van Gieson Elastin stain set (25089-
1, Astral Diagnostics) according to the manufacturer’s instructions. Seven
micrometer human aortic sections were deparaffinized as aforementioned and
hematoxylin-eosin (H&E) staining was performed by incubating the slides 1.5 min
in eosin 515 LT (3801619, Leica Biosystems) and 2 min in hematoxylin 560 MX
(3801575, Leica Biosystems).
Western blotting. Samples were homogenized in RIPA buffer (98065; Cell Sig-
naling Technologies). Forty micrograms of denatured proteins were loaded onto a
10% Mini-PROTEAN TGX gel (#456-8034, Bio-Rad) for SDS-PAGE. Proteins
were transferred on PVDF membranes (#BR20160719, Bio-Rad) using a Trans-Blot
Turbo Transfer System (Bio-Rad). Membranes were blocked and probed for
netrin-1 (1:500 dilution; ab126729, Abcam) and GAPDH (1:1000 dilution; ab8245,
Abcam). Secondary biotinylated antibodies goat anti-rabbit (1:5000 dilution;
A0545, Sigma Aldrich) or goat anti-mouse (1:5000 dilution; A9917, Sigma Aldrich)
were applied before revelation with Clarity Western ECL (#170-5060, Bio-Rad) and
imaged on a ChemiDoc Imaging System (Bio-Rad). Uncropped blot images are
shown in Supplementary Figure 6. Mean netrin-1 band intensity was measured
with ImageJ and normalized over GAPDH mean band intensity.
Calcium imaging. Mice primary VSMCs were seeded in 96-Well Clear Bottom
Black Polystyrene Microplates (3603; Corning) at a density of 2 × 105 cells/well.
The cells were allowed to adhere for 24 h in complete DMEM medium at 37 °C and
5% CO2. Cells were then loaded for 30 min with Calcium tracker Fura-2 (1 μM;
F1221, Thermo Fisher Scientific). Cells were washed and incubated for an addi-
tional 15 min in PBS. A volume of 100 µl of DMEM or DMEM without Calcium
(21068028; Thermo Fisher Scientific) was then added to each well. Baseline
fluorescence was acquired on a FlexStation 3® Multi-Mode Microplate Reader
(Molecular Devices). Light emission was acquired at 550 nm following excitation at
340 (Calcium-bound Fura-2 max excitation peak) and 380 nm (Calcium-free Fura-
2 max excitation peak). Recombinant mouse netrin-1 (1109-N1, R&D Systems)
was then directly loaded to each well (final concentration 2.5 µg/ml), and changes
in fluorescence max excitation peak were monitored for 30 min. Data were
expressed as the ratio of values captured at 340 nm and 380 nm wavelengths (340/
380 ratio).
Statistical analysis. Categorical data are presented as percentages. Continuous
variables are shown as the means±s.e.m. Two-tailed, unpaired Student’s t-test was
used to compare two groups of continuous data. Comparisons among more than
two independent groups were analyzed by one-way or two-way analysis of variance
(ANOVA), followed by Tukey or Dunnett multiple comparison tests when
appropriate. Two-sided Fisher’s exact test has been used to compare categorical
variables. Linear regression was computed for two-variable correlation. Goodness
of fit and 95% interval bands are as indicated. Statistical significance of Kaplan-
Meier survival curves was assessed with a Mantel-Cox test. Analyses were
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performed with Prism 7 software (GraphPad software Inc., CA, USA). P values <
0.05 were considered significant.
Data availability
The data and computer codes that support our findings are available from the
corresponding author upon reasonable request. All RNA sequencing datasets are
deposited in Gene Expression Omnibus (GEO)-accession number GSE118237
(GSM3323357 for the CLOUPE file used to generate Fig. 3a–d and f and the
Supplementary Tables 1 and 2) and GSE118217 (GSM3321219 to GSM3321226 for
each individual sample used to generate Fig. 4a and b, and Supplementary Fig-
ure 2a and b). A reporting summary for this Article is available as a Supplementary
Information file.
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